COMMUNIQUÉS West-GlobeNewswire

Medtronic Announces FDA Approval and U.S. Launch of Next Generation Spinal Cord Stimulator for Chronic Pain Management

18/09/2017 - 15:00

The Intellis Platform Includes the World's Smallest Implantable Spinal Cord Stimulator and Offers Personalized Pain Relief and Advanced Activity Tracking DUBLIN - September 18, 2017 - Medtronic plc (NYSE:MDT) today [...]

AroCell AB: New application for AroCell TK 210 ELISA opens new opportunities for drug development research

18/09/2017 - 14:15

Uppsala September 18, 2017 PRESS RELEASE New application for AroCell TK 210 ELISA opens new opportunities for drug development research AroCell AB (publ) announces today that an abstract submitted by Kiran Kumar [...]

Prothena Presents New Research Supporting Clinical Relevance of Cardiac Biomarker NT-proBNP in AL Amyloidosis

18/09/2017 - 14:00

Preclinical Research Demonstrating a Direct Relationship Between Misfolded Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP Response and Health-related [...]

Advanced Bifurcation Systems to Sponsor XIII European Bifurcation Club Meeting

18/09/2017 - 13:55

LOS ANGELES, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems ("ABS" or the "Company"), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations [...]

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

18/09/2017 - 13:00

PRESS RELEASE Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases $40 million investment to accelerate development of Immunocore's ImmTAV® and ImmTAB® [...]

Solon Eiendom ASA : Primary insider notification

18/09/2017 - 08:30

(Oslo, Norway, 15 September 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 155,259 shares in Solon Eiendom ASA at a price of NOK 17.9561 per [...]

Cambridge Medical Robotics closes Series A fundraise with further $26 million

18/09/2017 - 08:00

Cambridge Medical Robotics Limited ("CMR" or the "Company") Cambridge Medical Robotics closes Series A fundraise with further $26 million Cambridge, UK, 18 September 2017 : Cambridge Medical Robotics Ltd, the private [...]

Saniona AB: Saniona reports encouraging start for tesofensine Phase 3 study

18/09/2017 - 08:00

PRESS RELEASE September 18, 2017 Saniona, a leading biotech company in the field of ion channels, today announces that Saniona's partner, Medix, has recruited 150 out of the planned 372 patients in the study during the [...]

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

18/09/2017 - 08:00

PRESS RELEASE Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases $40 million investment to accelerate development of Immunocore's ImmTAV® and ImmTAB® [...]

ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)

18/09/2017 - 07:30

Leuven, Belgium, 18 th September, 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for retinal disorders, with a focus on diabetic eye disease, announced today that [...]

INNATE PHARMA,: Premier semestre 2017 : Nouvelles données cliniques et enrichissement du portefeuille

18/09/2017 - 07:00

PREMIER SEMESTRE 2017 : NOUVELLES DONNÉES CLINIQUES ET ENRICHISSEMENT DU PORTEFEUILLE Trésorerie, équivalents de trésorerie et actifs financiers [1] s'élevant à 204,1 millions d'euros au 30 juin 2017 Importants progrès [...]

INNATE PHARMA, First half of 2017: delivering key clinical data and strengthening the pipeline

18/09/2017 - 07:00

first half of 2017: DELIVERING KEY CLINICAL Data and strengthening the Pipeline Cash, cash equivalents and financial assets [1] for the Company amounted to €204.1m (million euros) as of June 30, 2017 Significant [...]

Addex Makes Changes to Executive Management Team

18/09/2017 - 07:00

Geneva, Switzerland, 18 September 2017 - Addex Therapeutics (SIX: ADXN) announced today that Robert Lutjens, Head of Discovery will join the Executive Management Team and take over scientific leadership with support [...]

Novartis' Xolair® confirms re-treatment efficacy in chronic spontaneous urticaria patients after treatment interruption

16/09/2017 - 16:00

OPTIMA Phase IIIb data re-confirm that almost two thirds of patients treated with Xolair 300 mg for 6 months are well-controlled[1] Should a treatment pause be necessary, data showed almost 90% of chronic spontaneous [...]

Sanofi and Regeneron Announce Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis

16/09/2017 - 08:15

Sanofi and Regeneron Announce Positive Study Results for Dupixent ® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis - Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European [...]

Sanofi et Regeneron annoncent les résultats positifs d'une étude consacrée à Dupixent® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère

16/09/2017 - 08:15

Sanofi et Regeneron annoncent les résultats positifs d'une étude consacrée à Dupixent ® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère - Présentation orale des résultats de l'étude de phase 3 [...]

Summit Therapeutics Announces Exercise of Underwriters' Over-Allotment Option

15/09/2017 - 19:29

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Summit Therapeutics plc (" [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2017

15/09/2017 - 17:00

Communiqué de presse Villepinte, le 15 septembre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Shire Debuts MYDAYIS® and New Research at the 30th Annual Psych Congress

15/09/2017 - 13:00

Shire Debuts MYDAYIS ® and New Research at the 30 th Annual Psych Congress Lexington, MA - September 15, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) will share new Attention Deficit Hyperactivity Disorder (ADHD) research [...]